GILMAN STEVEN C - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 6, 2024, GILMAN STEVEN C's relationship to Akebia Therapeutics, Inc. (AKBA) is Director, and currently has 117,130 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKBA insiders.
Data Source: SEC.
GILMAN STEVEN C - Insider Non-Derivative Transactions of AKBA Common Stock
GILMAN STEVEN C - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 7, 2024 | Acquisition -- (Common Stock) | 30000 | 0 | 117130 |
| Jun 7, 2023 | Acquisition -- (Common Stock) | 30000 | 0 | 87130 |